NYSEARCA:PJP Invesco Pharmaceuticals ETF (PJP) Price, Holdings, & News $95.15 +0.27 (+0.28%) As of 12:38 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestBuy This Stock About Invesco Pharmaceuticals ETF (NYSEARCA:PJP) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get PJP alerts:Sign Up Key Stats Today's Range$94.94▼$95.6450-Day Range$80.73▼$95.6552-Week Range$72.25▼$96.00Volume4,213 shsAverage Volume7,137 shsMarket Capitalization$272.13 millionAssets Under Management$271.44 millionDividend Yield1.04%Net Expense Ratio0.56%Aggregate RatingModerate Buy ETF Overview PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. The Index consists of stocks of 30 United States pharmaceutical companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The Fund normally invests at least 90% of its total assets in common stocks that consists of the Index. The Fund's investment advisor is Invesco PowerShares Capital Management LLC. Read More Invesco Pharmaceuticals ETF ExpensesTypePJPHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.50%0.56%0.56%0.51%0.53%Other Expenses0.06%0.47%0.56%0.59%0.56%Total Expense0.56%0.75%0.76%0.74%0.73%Fee Waiver0.00%-0.67%-0.66%-0.71%-0.63%Net Expense0.56%0.60%0.63%0.58%0.60% Receive PJP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Invesco Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PJP ETF News HeadlinesInvesco Dynamic Pharmaceuticals ETF declares quarterly distribution of $0.2668June 23, 2025 | msn.comPharma stocks gain as traders have doubts on Trump's executive order to lower drug pricesMay 13, 2025 | morningstar.comMRobinhood warningA strange chasm is coming to Wall Street... It's already creating millionaires and billionaires at the fastest pace in history. CNBC calls it "the largest wealth creation spree in history." Yet 1 in 3 Americans now fear their financial situation is deteriorating. There's only one way to survive, says the man who predicted 2008 and 2020, but sadly it's already too late for many.October 9 at 2:00 AM | Stansberry Research (Ad)PJP: The Pharma Executive Order May Be InconsequentialMay 13, 2025 | seekingalpha.comPJP: Big Pharma Concentration Risks Amid Looming Confirmation Of RFK Jr.December 26, 2024 | seekingalpha.comHow Is Merck's Stock Performance Compared to Other Pharmaceuticals Stocks?December 6, 2024 | msn.comSee More Headlines PJP ETF - Frequently Asked Questions How have PJP shares performed this year? Invesco Pharmaceuticals ETF's stock was trading at $82.62 at the start of the year. Since then, PJP stock has increased by 15.2% and is now trading at $95.1490. How do I buy shares of Invesco Pharmaceuticals ETF? Shares of PJP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Invesco Pharmaceuticals ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that Invesco Pharmaceuticals ETF investors own include NVIDIA (NVDA), Meta Platforms (META), Walt Disney (DIS), Affirm (AFRM), Advanced Micro Devices (AMD), Netflix (NFLX) and Pfizer (PFE). Fund Details IssuerInvesco Fund NameInvesco Pharmaceuticals ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:PJP Inception Date6/23/2005 Fund ManagerPeter Hubbard, Michael Jeanette, Pratik Doshi, Tony Seisser Webwww.invescopowershares.com Phone+1-800-9830903Fund Focus Asset ClassEquity BenchmarkDynamic Pharmaceutical Intellidex Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings33 Fund Statistics Assets Under Management$271.85 million Average Daily Volume$6.34 thousand Discount/Premium0.06% Administrator, Advisor and Custodian AdministratorThe Bank of New York Mellon Corporation AdvisorInvesco Capital Management, LLC CustodianThe Bank of New York Mellon Corporation DistributorInvesco Distributors, Inc. Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerCitadel Options OptionableOptionable Options Volume2 Put Options2 Call Options2 Short Interest1,600 shs Miscellaneous Outstanding Shares2,860,000Beta0.66 Creation Unit10,000 Creation Fee$500.00 (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free Report Top 10 PJP HoldingsAbbVie (NYSE:ABBV)Holding Weight: 5.22%Abbott Laboratories (NYSE:ABT)Holding Weight: 5.03%Eli Lilly and Company (NYSE:LLY)Holding Weight: 4.98%Johnson & Johnson (NYSE:JNJ)Holding Weight: 4.95%Gilead Sciences (NASDAQ:GILD)Holding Weight: 4.89%Pfizer (NYSE:PFE)Holding Weight: 4.78%Amgen (NASDAQ:AMGN)Holding Weight: 4.76%Merck & Co., Inc. (NYSE:MRK)Holding Weight: 4.63%United Therapeutics (NASDAQ:UTHR)Holding Weight: 3.82%Travere Therapeutics (NASDAQ:TVTX)Holding Weight: 3.77%Full Holdings DetailsPJP Sector ExposurePJP Industry Exposure This page (NYSEARCA:PJP) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredA Huge Shift Is Underway in AmericaWall Street legend issues chilling new warning: "I've never seen anything as dangerous as this" The man who...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
